Imaging

Top Story

CMR more accurate than SPECT at predicting major adverse CV events

May 16, 2016

Read the Perspective from Nathaniel Reichek, MD

Regardless of CV risk factors, angiography results or initial patient treatment, CV magnetic resonance is a stronger predictor of major adverse CV events than single-photon emission CT, according to new data from the CE-MARC study.

Between March 2006 and August 2009, the researchers randomly assigned 752 patients with suspected stable angina to CV magnetic resonance (CMR) followed by SPECT or SPECT followed by CMR. The primary outcome was major adverse CV events. Follow-up lasted approximately 5 years. The final-analysis population included 628 patients.

Meeting News Coverage

Mapping can identify individual drivers that maintain ventricular fibrillation

May 10, 2016
SAN FRANCISCO — Ventricular fibrillation mapping can accurately identify individual drivers, according to data presented at the Heart Rhythm Society Annual…
FDA News

MRI-safe CRT-D approved by FDA

May 9, 2016
Biotronik announced that the FDA approved its MRI-conditional cardiac resynchronization therapy defibrillator for patients with HF.The device (Iperia ProMRI HF-T), which…
Meeting News CoverageVideo

VIDEO: ‘Harder look’ required in patients with an ACS but no obstructive disease

May 7, 2016
CHICAGO — Jennifer Ann Tremmel, MD, an interventional cardiologist at Stanford University Medical Center, discusses alternative diagnoses in ACS in patients…
In the JournalsPerspective

CMR more accurate than SPECT at predicting major adverse CV events

May 16, 2016
Regardless of CV risk factors, angiography results or initial patient treatment, CV magnetic resonance is a stronger predictor of major adverse CV…

Meeting News Coverage

Mapping can identify individual drivers that maintain ventricular fibrillation

May 10, 2016
SAN FRANCISCO — Ventricular fibrillation mapping can accurately identify individual drivers, according to data presented at the Heart Rhythm…

FDA News

MRI-safe CRT-D approved by FDA

May 9, 2016
Biotronik announced that the FDA approved its MRI-conditional cardiac resynchronization therapy defibrillator for patients with HF.The device (Iperia…

Meeting News CoverageVideo

VIDEO: ‘Harder look’ required in patients with an ACS but no obstructive disease

May 7, 2016
CHICAGO — Jennifer Ann Tremmel, MD, an interventional cardiologist at Stanford University Medical Center, discusses alternative diagnoses in…

In the Journals

Higher muscle mass may lower mortality risk in CVD

May 3, 2016
Patients with CVD who have higher muscle mass may have a lower mortality risk than patients with different body compositions, according to data…

Meeting News Coverage

Plaque composition, morphology does not differ by sex in patients with stable CAD

April 27, 2016
CHICAGO — Except for a greater plaque burden in men, women and men with stable CAD have similar plaque morphology and composition, according to…

In the Journals

IVUS-guided PCI superior to angiography guidance for reduction of MACE

April 21, 2016
In patients who undergo drug-eluting stent implantation for diffuse coronary lesions, the use of IVUS guidance appears superior to angiography…

Meeting News Coverage

Novel agent improves myocardial perfusion imaging in patients with obesity

April 19, 2016
CHICAGO — A novel PET agent for myocardial perfusion imaging had better sensitivity than and similar specificity to myocardial perfusion…

In the Journals

Improving evidence base around carotid testing may reduce use of low-value imaging

April 18, 2016
Clarification of current guidelines and development of decision support tools may improve the evidence base around carotid testing and reduce the use…

In the JournalsPerspective

Coronary CTA useful in patients with suspected angina due to CHD

April 15, 2016
Coronary CT angiography was associated with more appropriate use of invasive angiography and more use of preventive therapies in patients with…

More Headlines »